Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Children's Oncology Group
Essen Biotech
St. Jude Children's Research Hospital
OncoNano Medicine, Inc.
Wake Forest University Health Sciences
University of Southern California
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
AVM Biotechnology Inc
Arcus Biosciences, Inc.
University of Alabama at Birmingham
Novartis
Checkpoint Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Biologics & Biosimilars Collective Intelligence Consortium
Scripps Health
University Hospital Southampton NHS Foundation Trust
Jonsson Comprehensive Cancer Center
Celgene
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Barbara Ann Karmanos Cancer Institute
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Indiana University
University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)